Who Paid My Doc
Yuri Zarate
Clinical Genetics (M.D.) Lexington, KY Medical Doctor
NPI 1649488164 CMS profile 1207270
740 S Limestone Ste K201, Lexington, KY 40536
General payments
$1,243
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$208,162
Through program year 2025, Yuri Zarate of Lexington, KY is reported in the CMS Open Payments database as having received $1,243 across 11 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $208,162 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 61st percentile of Clinical Genetics (M.D.) profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $742 | 3 | |
| 2024 | General | $86 | 2 | |
| 2023 | General | $188 | 3 | |
| 2022 | General | $114 | 1 | |
| 2019 | General | $112 | 2 |
Beside peers
- Yuri Zarate
- Clinical Genetics (M.D.) median
- Middle half of Clinical Genetics (M.D.)
- National median
In program year 2025, general payments to Yuri Zarate were reported at $742. Among 315 Clinical Genetics (M.D.) profiles paid that year, the median was $255 and the middle half received between $85 and $3,583.
Show as a table
| Year | Yuri Zarate | Clinical Genetics (M.D.) median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $112 | $130 | $24–$2,691 | $163 |
| 2020 | $0 | $126 | $30–$3,700 | $114 |
| 2021 | $0 | $185 | $30–$3,777 | $132 |
| 2022 | $114 | $136 | $44–$2,749 | $149 |
| 2023 | $188 | $196 | $55–$5,220 | $160 |
| 2024 | $86 | $165 | $46–$3,171 | $164 |
| 2025 | $742 | $255 | $85–$3,583 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
13
Drug cost
$1,222
Branded share of claims
100%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Levocarnitine Levocarnitine (With Sugar) | Brand | 13 | $1,222 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero.
Billing to Medicare
Part B · data year 2024 · 3 billing codesPaid by Medicare
$2,503
Medicare patients
17
Services billed
36
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
11 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Genetics (M.D.) in Kentucky
Related records
Clinical Genetics (M.D.) in Kentucky
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Genetics (M.D.)
Everyone recorded under this specialty, nationwide.
Doctors in Kentucky
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.